2015 Annual Meeting | 1HC.008 - Neuromuscular Junction Disorders

Date Saturday 04/18/15

Time 01:00 PM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Half-Day Course

Director(s) Robert M. Pascuzzi, MD, FAAN

Topic(s)

Learning Objectives Participants should be familiar with the diagnosis and management of patients with myasthenia gravis and related disorders; learn to critically select therapies; and be able to distinguish myasthenia gravis, MuSK myasthenia, Lambert-Eaton syndrome, and recognize the less common diosorders of neuromuscular transmission.

CME Available 3.75 CME credits

Core Competencies Patient Care & Procedural Skills, Professionalism, Medical Knowledge

Recommended Audience Trainee, General Neurologist, Specialist Neurologist

Teaching Styles Case-based, Didactic

Event Timeline
01:00 PM - 01:05 PM		Introduction Robert M. Pascuzzi, MD, FAAN
01:05 PM - 01:55 PM		Presentation and Diagnosis of Myasthenia Gravis Janice M. Massey, MD, FAAN
01:55 PM - 02:45 PM		Treating Myasthenia Gravis in 2014: Evidence-based, Cost-effective, and New Developments Richard J. Barohn, MD, FAAN
02:45 PM - 02:55 PM		Discussion
02:55 PM - 03:10 PM		Break
03:10 PM - 04:00 PM		Toxins and Disorders of Neuromuscular Transmission Laura M. Tormoehlen, MD, FAAN
04:00 PM - 04:50 PM		Lambert-Eaton Syndrome and the Less Common Disorders of Neuromuscular Transmission Robert M. Pascuzzi, MD, FAAN
04:50 PM - 05:00 PM		Discussion

Faculty Disclosures
Richard J. Barohn, MD, FAAN	Dr. Barohn has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for NuFactor. The institution of Dr. Barohn has received research support from FDA OPD R01. Dr. Barohn has received intellectual property interests from a discovery or technology relating to health care.
Janice M. Massey, MD, FAAN	Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenix. Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance Therapeutics. Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Momenta. The institution of Dr. Massey has received research support from Revance .
Robert M. Pascuzzi, MD, FAAN	Dr. Pascuzzi has nothing to disclose.
Laura M. Tormoehlen, MD, FAAN	The institution of Dr. Tormoehlen has received research support from Genentech. Dr. Tormoehlen has received publishing royalties from a publication relating to health care.

��ɫ��

��ɫ��